Paperpal Prime Logo

The Lancet Microbe : Impact Factor & More

eISSN: 2666-5247pISSN: 2666-5247
JournalOpen Access

Key Metrics

CiteScore
18.4
Scite Index
0.89 5-Year SI
SNIP
6.5
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on The Lancet Microbe

The Lancet Microbe Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Monthly
Article Processing ChargesUSD 6300
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2020
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 6
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in The Lancet Microbe ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in The Lancet Microbe

Minimal supply chain and forecasting testing volumes for clinical bacteriology laboratories in resource-limited settings for individual patient care: a costing study.
  • 23 Jul 2027
  • The Lancet. Microbe
Context-dependent and ecological drivers of neonatal invasive Escherichia coli population dynamics.
  • 19 May 2027
  • The Lancet. Microbe
Context-dependent and ecological drivers of neonatal invasive Escherichia coli population dynamics-Authors' reply.
  • 19 May 2027
  • The Lancet. Microbe
Advances in tuberculosis diagnostics and biomarkers, 2020-26: scientific evidence, recommendations, gaps, and developmental priorities.
  • 27 Apr 2027
  • The Lancet. Microbe
Advances in tuberculosis treatment: novel regimens, new drug pipelines, host-directed therapies, and updated management guidelines.
  • 26 Apr 2027
  • The Lancet. Microbe
State of the global tuberculosis epidemic: burden, progress towards WHO End TB Strategy targets and systemic challenges.
  • 26 Apr 2027
  • The Lancet. Microbe
Minimal supply chain and forecasting testing volumes for clinical bacteriology laboratories in resource-limited settings for individual patient care: a costing study.
  • 23 Jul 2027
  • The Lancet. Microbe
Context-dependent and ecological drivers of neonatal invasive Escherichia coli population dynamics.
  • 19 May 2027
  • The Lancet. Microbe
Context-dependent and ecological drivers of neonatal invasive Escherichia coli population dynamics-Authors' reply.
  • 19 May 2027
  • The Lancet. Microbe
Advances in tuberculosis diagnostics and biomarkers, 2020-26: scientific evidence, recommendations, gaps, and developmental priorities.
  • 27 Apr 2027
  • The Lancet. Microbe
Advances in tuberculosis treatment: novel regimens, new drug pipelines, host-directed therapies, and updated management guidelines.
  • 26 Apr 2027
  • The Lancet. Microbe
State of the global tuberculosis epidemic: burden, progress towards WHO End TB Strategy targets and systemic challenges.
  • 26 Apr 2027
  • The Lancet. Microbe

FAQs on The Lancet Microbe